BioTransplant, Immerge BioTherapeutics Inc., Novartis Pharma AG deal

NVS and BTRN named their xenotransplantation joint venture Immerge BioTherapeutics Inc. Immerge began operation on Jan. 2 and will specialize in xenotransplantation of cells, tissues and organs. The c...